N-[(Thiophen-2-yl)methyl]adamantane-1-carboxamide

Catalog No.: 
ACBLHN852
CAS No.: 
339098-64-5
Molecular Formula: 
C16H21NOS
Molecular Weight: 
275.42
N-[(Thiophen-2-yl)methyl]adamantane-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$104.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1599.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(Thiophen-2-yl)methyl]adamantane-1-carboxamide
IUPAC NameN-(thiophen-2-ylmethyl)adamantane-1-carboxamide
MDL No.MFCD01935928
Molecular FormulaC16H21NOS
Molecular Weight275.42
SMILESO=C(C12CC3CC(C2)CC(C3)C1)NCC4=CC=CS4
InChI KeyWRKJLJSHAQOMAK-UHFFFAOYSA-N
SynonymN-(2-THIENYLMETHYL)-1-ADAMANTANECARBOXAMIDE;N-[(thiophen-2-yl)methyl]adamantane-1-carboxamide;Tricyclo[3.3.1.13,7]decane-1-carboxamide, N-(2-thienylmethyl)-;N-(2-Thienylmethyl)tricyclo[3.3.1.13,7]decane-1-carboxamide
CAS No.339098-64-5

Synthetic Route by SureRoute

1. ACBLHN852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZQIR475 route compound structure diagram
    ACZQIR475828-51-3In Stock
  4. Then
  5. ACBLHN852 route product structure diagram
    ACBLHN852339098-64-5
Inquiry

2. ACBLHN852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYNLZ013 route compound structure diagram
    ACYNLZ013711-01-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLHN852 route product structure diagram
    ACBLHN852339098-64-5
Inquiry

3. ACBLHN852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBLHN852 route product structure diagram
    ACBLHN852339098-64-5
Inquiry

Comments (0)